CMV-specific Cell-mediated Immunity at 3-month Prophylaxis Withdrawal Discriminates D+/R+ Kidney Transplants at Risk of Late-onset CMV Infection Regardless the Type of Induction Therapy-Reference-Cited by-同舟云学术

CMV-specific Cell-mediated Immunity at 3-month Prophylaxis Withdrawal Discriminates D+/R+ Kidney Transplants at Risk of Late-onset CMV Infection Regardless the Type of Induction Therapy

Published:2018-11 Issue:11 Volume:102 Page:e472-e480
ISSN:1534-6080
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Jarque Marta,Melilli Edoardo,Crespo Elena,Manonelles Anna,Montero Nuria,Torras Joan,Cruzado Josep M.,Luque Sergi,Gil-Vernet Salvador,Grinyó Josep M.,Bestard Oriol

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference21 articles.

1. Infection in solid-organ transplant recipients;N Engl J Med,2007

2. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients;Am J Transplant,2002

3. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival;Kidney Int,2004

4. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation;Transplantation,2018

5. Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: long-term results after 7 years of a randomized clinical trial;Transplantation,2018

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogen-specific cell-mediated immunity to guide the management of cytomegalovirus in solid organ transplantation: state of the art clinical review;Expert Review of Clinical Immunology;2024-07-24

2. Using a commercially available assay that measures cytomegalovirus (CMV)-specific T-cell immunity to predict protection against CMV: A prospective, blinded clinical study;Diagnostic Microbiology and Infectious Disease;2024-02

3. Cytomegalovirus Cell-mediated Immunity Assays in Pediatric Transplantation;Journal of the Pediatric Infectious Diseases Society;2024-02-01

4. The use of lymphocyte-depleting antibodies in specific populations of kidney transplant recipients: A systematic review and meta-analysis;Transplantation Reviews;2023-12

5. QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients;Transplantation;2023-11-22